当前位置: 首页 >> 检索结果
3024. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.
作者: Suetonia C Palmer.;Jonathan C Craig.;Sankar D Navaneethan.;Marcello Tonelli.;Fabio Pellegrini.;Giovanni F M Strippoli.
来源: Ann Intern Med. 2012年157卷4期263-75页
Statins have uncertain benefits in persons with chronic kidney disease (CKD) because individual trials may have insufficient power to determine whether treatment effects differ with severity of CKD.
3025. Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis.
作者: Ashish Upadhyay.;Amy Earley.;Jenny L Lamont.;Shana Haynes.;Christoph Wanner.;Ethan M Balk.
来源: Ann Intern Med. 2012年157卷4期251-62页
Lipid-lowering therapy is not widely used in persons with chronic kidney disease (CKD) despite a high burden of dyslipidemia and cardiovascular disease in this population.
3026. Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study.
作者: Olaide Y Raji.;Stephen W Duffy.;Olorunshola F Agbaje.;Stuart G Baker.;David C Christiani.;Adrian Cassidy.;John K Field.
来源: Ann Intern Med. 2012年157卷4期242-50页
External validation of existing lung cancer risk prediction models is limited. Using such models in clinical practice to guide the referral of patients for computed tomography (CT) screening for lung cancer depends on external validation and evidence of predicted clinical benefit.
3027. Low-level lead exposure and the prevalence of gout: an observational study.
Blood lead levels (BLLs) less than 1.21 µmol/L (<25 µg/dL) among adults are considered acceptable by current national standards. Lead toxicity can lead to gouty arthritis (gout), but whether the low lead exposure in the contemporary general population confers risk for gout is not known.
3028. Role of colonoscopy and polyp characteristics in colorectal cancer after colonoscopic polyp detection: a population-based case-control study.
作者: Hermann Brenner.;Jenny Chang-Claude.;Lina Jansen.;Christoph M Seiler.;Michael Hoffmeister.
来源: Ann Intern Med. 2012年157卷4期225-32页
Studies have identified characteristics of adenomas detected on colonoscopy to be predictive of adenoma recurrence.
3029. Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention.
作者: Bryce D Smith.;Rebecca L Morgan.;Geoff A Beckett.;Yngve Falck-Ytter.;Deborah Holtzman.;John W Ward.
来源: Ann Intern Med. 2012年157卷11期817-22页
The Centers for Disease Control and Prevention (CDC) and a group of governmental and private sector partners developed these evidence-based recommendations to increase the proportion of hepatitis C virus (HCV)-infected persons who know their status and are linked to appropriate care and treatment. The recommendations also address brief alcohol screening, as alcohol accelerates progression of liver disease among HCV-infected individuals. These recommendations augment CDC's 1998 and 1999 recommendations based on risk and medical indications and are not meant to replace those recommendations.
3030. Screening for hearing loss in older adults: U.S. Preventive Services Task Force recommendation statement.
Update of the 1996 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for hearing impairment in older adults.
3032. Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis.
作者: Lisa Hartling.;Ahmed M Abou-Setta.;Serdar Dursun.;Shima S Mousavi.;Dion Pasichnyk.;Amanda S Newton.
来源: Ann Intern Med. 2012年157卷7期498-511页
Debate continues about the comparative benefits and harms of first-generation antipsychotics (FGAs) and second-generation antipsychotics (SGAs) in treating schizophrenia.
|